Clinical Trial Update: Study of INBRX-109 in Conventional Chondrosarcoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating INBRX-109 for conventional chondrosarcoma is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chondrosarcoma

Drugs mentioned

• INBRX-109 (INBRX-109)

Snippet

Sponsor: Inhibrx Biosciences, Inc | Conditions: Conventional Chondrosarcoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING